BREAST RECONSTRUCTION MARKET ANALYSIS

Breast Reconstruction Market, By Product Type (Implant, Tissue Expander, and Acellular Dermal Matrix), By Shape (Round, Teardrop, Crescent, and Others), By Procedure (Immediate Reconstruction, Delayed Reconstruction, and Revision Surgery), By End User (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

In September 2024, ACTREC (Advanced Centre for Treatment, Research and Education in Cancer), a part of Tata Memorial Centre, performed Western India's first whole breast reconstruction using Biological Mesh (Braxon). Led by Dr. Amar Deshpande and his team, the innovative procedure is quicker, taking 2-3 hours, less painful, and reduces recovery time to 3-4 weeks.
On March 27, 2024, GC Aesthetics, a global leader in the design, manufacturing, and distribution of breast implants, introduced the FixNip NRI, a nipple implant designed for women who have undergone breast reconstruction surgery. Positioned as a revolutionary solution, the device addresses the limitations of traditional techniques, offering a long-term aesthetic option for reconstructing the nipple-areola complex.
In June 2022, CollPlant, a regenerative medicine company specializing in 3D bioprinting and plant-based collagen technology, initiated a large-animal study for its 3D bioprinted regenerative breast implant program, aimed at advancing breast reconstruction solutions
In May 2022, GC Aesthetics, a global medical technology company focused on aesthetic and reconstructive surgery, launched the FixNip NRI implant, designed for nipple and areola complex (NAC) reconstruction, addressing a critical need for women worldwide